logo
NYC restaurants catering to Ozempic crowd with single meatballs, 1-ounce hamburgers and caviar nibbles

NYC restaurants catering to Ozempic crowd with single meatballs, 1-ounce hamburgers and caviar nibbles

New York Post10 hours ago

It's the tapas of the town.
Restaurants across New York City are increasingly adding single, flavor-packed bites to their menus to accommodate customers with shrinking appetites due to weight-loss medications such as Ozempic, Wegovy and Mounjaro. According to some surveys, as many as 1 in 8 Americans have tried the drugs.
People come in and 'they're not shy about saying they're on Ozempic,' said Max Tucci, the restaurateur behind the buzzy Tucci in NoHo. To better serve such guests, the Italian restaurant recently started offering its caviar-topped arancini in a single portion for $12 — instead of the usual three arancini for $34.
4 Tucci offers an individual serving of its arancini for diners with smaller appetites. People come in and 'they're not shy about saying they're on Ozempic,' said restaurateur Max Tucci.
Emmy Park for NY Post
Guests can also order a single meatball for $10, instead of the usual $27 portion, which includes three of the signature item, featuring manchego cheese and a Calabrian chili marinara.
'If more people are going through this and they're experiencing this, and their appetites are suppressed, then let's offer them something sweet and simple,' Tucci told The Post of his motivation. It's a win for the restaurant, he added, because it results in less food waste.
Clinton Hall, a beer-and-burger joint with several locations in Manhattan and one in the Bronx, is known for its hearty offerings, such as 'The CH Challenge' — a 20-ounce beef patty dressed with bacon, cheese, chicken tenders, crispy onion rings and more for $50.
But, it recently introduced a Teeny Weeny Mini Meal for summer that features two 1-ounce beef patties and baby buns.
'[Diners are] being a little bit more conscious about their intake,' Clinton Hall's culinary marketing director Gregory Mecane told The Post. This is a playful way 'to serve bold flavor in portions that reflect more and more adults' shrinking appetites.'
Other restaurants aren't altering their menus, but they're finding that diners have a bigger appetite for small, luxurious bites. Customers want bold flavor without the food coma.
At The Noortwyck in the West Village, an appetizer featuring a single hash brown topped with caviar and crème fraîche for $22 has long been on the menu. But, chef Andy Quinn admits the item's popularity has grown over the past year.
4 Clinton Hall recently added a Teeny Weeny Mini Meal (front) in addition to its big burger offerings.
Courtesy Gregory Mecane
It could very well 'be attributed to the rise in Ozempic [use],' he told The Post, adding that he's also observed tables ordering fewer dishes than they once did.
In Tribeca, the haute Japanese-French restaurants l'abeille recently nixed its five-course menu in favor of a three-course option to accommodate those with smaller appetites.
Owner Howard Chang said they've 'noticed people are eating less' perhaps due to weight-loss drugs.
He added they're happy to offer single portions of ala carte dishes, such as a squash blossom stuffed with New Caledonian blue prawn and saffron rice. Typically, two come to an order for $48, but those who ask can order just one.
4 The individual hash brown bites with caviar at The Noortwyck have been increasingly popular.
Courtesy of The Noortwyck
At other popular restaurants, restaurateurs might not acknowledge they're catering to GLP-1 users, but those with smaller appetites will certainly find appealing options.
Since it opened in early 2024, the upscale fried chicken joint Coqodaq has been famed for offering a singular chicken nugget topped with Golden Daurenki caviar for $28.
At Crevette, an elegant, rose-hued Mediterranean restaurant that opened in the West Village earlier this year from the team behind Dame, the menu is heavy on raw bar offerings.
However, there's no three-tiered seafood tower on offer but rather a large assortment of single, thoughtfully conceived bites, such as a chilled mussel with salsa brava for $2 or an individual razor clam with parsley and cucumber for $12.
4 At Coqodaq, the caviar-topped chicken nuggets pack a lot of luxury and flavor into a small package.
Evan Sung/COQODAQ
The trend seems likely to follow a similar path as the rise of low- and no-alcoholic cocktails. Not too long ago, those who didn't want to imbibe while eating out had limited options at NYC restaurants — typically just iced tea and soda.
Now, creative zero-proof cocktails — many with price tags only slightly lower than their boozy brethren — abound.
'We're always evolving. We're always learning,' Tucci said of himself and other city restaurateurs. 'If this is going to become a food trend and we're making money off of it too, then it's worth doing.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. wants every American to use ‘wearable' health data-collecting technology
RFK Jr. wants every American to use ‘wearable' health data-collecting technology

New York Post

time2 hours ago

  • New York Post

RFK Jr. wants every American to use ‘wearable' health data-collecting technology

Health and Human Services Secretary Robert Kennedy Jr. wants all Americans to use 'wearable' technology to track their health as part of his 'MAHA' agenda. The Kennedy-clan strongman revealed his agency's plan Tuesday for a massive push for Americans — who have an obesity rate of 40% — to use wearable data-collecting technology such as FitBits, Oura Rings, and Apple Watches, to promote healthier lifestyles. 'We're about to launch the biggest advertising campaign in HHS history to encourage Americans to use wearables,' Kennedy said in a House Committee on Energy and Commerce hearing on Tuesday. Advertisement 3 Robert Kennedy Jr. said he wants all Americans to use 'wearable' technology to track their health as part of his 'MAHA' agenda. X / @SecKennedy 'It's a way people can take control over their own health. They can take responsibility. They can see, as you know, what food is doing to their glucose levels, their heart rates, and a number of other metrics, as they eat it,' the secretary said in the statement, which was also posted to X. 'We think that wearables are a key to the MAHA agenda of making America healthy again and my vision is that every American is wearing a wearable in four years,' he concluded. Advertisement Kennedy expressed the belief that with accurate and timely health data, Americans will exert better judgment in their diet and will even opt for more exercise. The Trump official has previously argued during his Senate confirmation hearing that obesity in the United States poses a national security risk affecting military readiness. 3 Close up of a hand touching a smartwatch with a health app on the screen, a gadget for a fitness active lifestyle. sitthiphong – President Trump's nominee for Surgeon General, Dr. Casey Means, is also an advocate for wearable Continuous Glucose Monitor (CGM) products. Advertisement In a blog post for her own CGM-producing company, Levels, Means argued that the 'small plastic discs' can 'reduce global metabolic suffering' and provide much-needed help to the '93.2 percent of people' in the US suffering from metabolic issues. Means' Levels technology attaches to the users' arms and sends accurate, second-by-second metabolic data to their smartphone. 3 A diabetic woman with a glucose sensor uses a mobile phone to measure her blood sugar level. Pixel-Shot – Advertisement Kennedy revealed last week that coffee giant Starbucks will make MAHA-inspired amendments to its menu — though the company already avoids artificial flavors, dyes, high fructose corn syrup, and other unhealthy additives. RFK Jr. took his first pound of flesh off of Americans earlier this year when he outlawed the use of artificial dyes in American food products.

5 surprising stats on alcohol use disorder
5 surprising stats on alcohol use disorder

Miami Herald

time3 hours ago

  • Miami Herald

5 surprising stats on alcohol use disorder

5 surprising stats on alcohol use disorder Alcohol use disorder (AUD) is a serious and often misunderstood condition affecting millions of people in the United States. Despite alcohol's cultural normalization, AUD contributes to a staggering number of deaths each year and poses a major public health threat. Stigma, misinformation, and a lack of access to care continue to obscure who is affected, the role of co-occurring mental health conditions, and what treatment and recovery can look like. According to the Centers for Disease Control and Prevention (CDC), about 178,000 people die each year from excessive alcohol use. These deaths stem both from the effects of chronic alcohol use, including conditions like liver disease, heart disease, and certain cancers, and from acute consequences of binge drinking, such as motor vehicle crashes, overdoses, alcohol poisoning, and suicide. Alcohol-related death statistics Alcohol-related deaths are also rising. Between 2016 and 2021, deaths linked to alcohol increased by 29%, according to the CDC. This jump reflects a 27% increase in alcohol-related deaths among boys and men, and a 35% increase among girls and women, though men still account for a higher total number of deaths. The data underscores a concerning trend: excessive drinking, whether chronic or episodic, is becoming increasingly deadly across all demographics. The financial toll of alcohol use is also massive. According to federal estimates, substance misuse costs the U.S. about $740 billion each year in areas like lost productivity and healthcare. Alcohol use alone accounts for $249 billion of that total, including $27 billion in direct healthcare costs. To better understand the scope of this crisis, Charlie Health examined some of the most striking AUD statistics, from rising rates of alcohol misuse to the possible genetic components of AUD. We also share how people struggling with substance use disorder (SUD), including AUD, can access compassionate, evidence-based care. 1. Just over one in 10 Americans struggles with AUD According to the 2021 National Survey on Drug Use and Health from the Substance Abuse and Mental Health Services Administration (SAMHSA), just over one in 10 people age 12 or older (10.6%) had AUD in the past year. That amounts to 29.5 million people. While this staggering number highlights how common AUD is across all age groups, there are some populations that are more at risk than others. The percentage of people who had AUD in the past year was highest among young adults aged 18 to 25, about 1 in 7 of whom (15%) struggled with the condition, according to the SAMHSA (that's 5 million people). 2. Teens with depression might be more likely to struggle with alcohol misuse Data consistently shows that mental health and alcohol misuse are closely linked, especially during adolescence, a critical period for emotional development and risk-taking behaviors. According to the SAMHSA, teens ages 12 to 17 who had a major depressive episode in the past year were more than twice as likely to binge drink than those who didn't (6.7% compared to 3.1%, respectively). SAMHSA defines binge drinking as consuming more than four or five alcoholic drinks within a couple of hours on at least one day in the past month. 3. Adults with mental health conditions might binge drink at higher rates Similar links between mental health conditions and alcohol misuse are seen among adults. SAMHSA data shows that adults with mental health conditions were more likely to binge drink alcohol than those without. In fact, over half of adults with any or a serious mental health condition were binge drinkers compared to just 21% of those without a mental health condition. 4. There might be genetic risk factors for AUD Recent genetic research has begun to identify specific genetic variants linked to addiction risk. The 2023 study discovered 19 DNA changes affecting overall addiction susceptibility, including nine tied specifically to alcohol. Understanding these genetic factors may pave the way for more targeted and effective treatments. 5. Most people with SUDs don't get the treatment they need Despite how common substance use disorders (SUDs) are, most people who need care don't get it. In 2023, an estimated 54.2 million people needed treatment - but only 23% received it, according to American Addiction Centers. This treatment gap highlights not just the scale of the crisis, but the systemic barriers - like stigma, cost, and limited access - that continue to prevent people from getting help. Expanding access to affordable, evidence-based care is essential. This story was produced by Charlie Health and reviewed and distributed by Stacker. Stacker Media, LLC.

Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care
Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care

Yahoo

time4 hours ago

  • Yahoo

Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has increasingly prioritized weight loss as a key area of growth and innovation in its healthcare platform. In recent months, the company introduced a six-month Wegovy offer priced at $549 per month for eligible new customers. This initiative was designed to improve affordability and sustained access to prescription weight loss medication, bundled with holistic support such as clinical oversight and nutritional guidance. The program reflects Hims & Hers' broader strategy to make proven obesity treatments more connected and accessible through technology-driven, consumer-friendly healthcare delivery. Hims & Hers' platform currently offers bundled access to all strengths of Wegovy with around-the-clock care, clinical support and personalized nutrition coaching. This integrated approach, provided at a unified monthly price, is aimed at improving long-term health outcomes for people living with obesity. These efforts align with Hims & Hers' broader vision of consumer-centered healthcare that puts individuals at the center of care decisions and delivers a seamless patient experience across digital touchpoints. Weight loss is also deeply integrated into Hims & Hers' long-term strategy. The company identified weight loss among chronic conditions as being actively targeted through personalized, subscription-based telehealth offerings. It launched access to compounded and branded GLP-1 medications like semaglutide, addressing rising consumer demand and market shortages. Despite regulatory uncertainties, such as the FDA's February 2025 resolution of the semaglutide shortage, HIMS continues to expand its weight loss platform, reinforcing it as a high-growth specialty with significant consumer relevance. Eli Lilly and Company LLY has advanced its leadership in the obesity treatment space with key developments in both injectables and oral therapies. This month, Eli Lilly expanded access to all approved doses of Zepbound (tirzepatide) through its LillyDirect Self Pay Pharmacy Solutions platform, enhancing affordability and continuity of care for patients pursuing weight management. Complementing this, Eli Lilly's oral GLP-1 candidate, orforglipron, showed Phase 3 results with efficacy and safety comparable to injectable treatments, reinforcing the company's commitment to comprehensive obesity care. Amgen Inc. AMGN is actively advancing innovation in obesity care through differentiated, long-acting biologics. This month, Amgen unveiled full Phase 2 results for MariTide, a novel, monthly-dosed obesity treatment, showing up to 20% average weight loss and sustained cardiometabolic benefits over 52 weeks without a plateau. With improved tolerability from dose escalation, MariTide enters Phase 3 trials targeting obesity, Type 2 diabetes, cardiovascular disease, and sleep apnea, strengthening Amgen's position in the obesity therapeutics space Shares of Hims & Hers have surged 73.6% year to date compared with the industry's growth of 18.2%. Image Source: Zacks Investment Research HIMS' forward 12-month P/S of 3.6X is lower than the industry's average of 5.9X, but is higher than its five-year median of 2.6X. It carries a Value Score of C. Image Source: Zacks Investment Research The Zacks Consensus Estimate for HIMS' 2025 earnings per share suggests a 170.4% improvement from 2024. Image Source: Zacks Investment Research Hims & Hers stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY) : Free Stock Analysis Report Amgen Inc. (AMGN) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store